Indore Online Journal

Oral Mucositis Epidemiology Forecast, Diagnosis, Treatment Options | DelveInsight

 Breaking News
  • No posts were found

Oral Mucositis Epidemiology Forecast, Diagnosis, Treatment Options | DelveInsight

March 26
13:40 2020
Oral Mucositis Epidemiology Forecast, Diagnosis, Treatment Options | DelveInsight

“Oral Mucositis – Epidemiology Forecast-2030”

DelveInsight has launched a new report on Oral Mucositis – Epidemiology Forecast-2030

Some of the key facts of the Report:

  1. In 2017, US had the maximum number of incident cases of the total incident cases followed by Japan.
  2. Grade 3 or 4 Oral Mucositis occurs in around 85% of patients receiving high-dose radiotherapy.
  3. In 2017, the incident population of Oral Mucositis in the United States was 1,956,351.


Oral Mucositis (OM) is the most common, debilitating complication of cancer chemotherapy and radiotherapy. It is characterized by inflammation and ulceration in the oral cavity caused by the chemotherapeutic drug substances and radiotherapy used in cancer treatment. The symptoms appear after five to ten days after the chemotherapy treatment or 14 days after the start of radiotherapy. The early symptoms include erythema and light discoloration of the mucosa. As OM progresses, erosive lesions and ulcers are developed.

Mouth sores are extremely painful and are typically the most distressing manifestation. It has significant negative impact on patient’s quality of life (QOL). Potential complications of OM include pain, increased risk of local and systemic infections, bleeding, insufficient food intake, and delays in administration of radiotherapy and/or chemotherapy, dose reduction of the chemotherapy drugs, increased length of hospital stays, associated economic burdens and in some cases life-threatening infections (septicemia in neutropenic cases).

Request for Sample Pages :

“According to Delveinsight, females appear to be more likely than males to develop Oral mucositis.”

Scope of the Report

  • The Oral Mucositis report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
  • The Oral Mucositis Epidemiology Report and Model provide an overview of the risk factors and global trends of Oral Mucositis in the seven major markets (7MM:US, France, Germany, Italy, Spain, UK, and Japan)
  • The report provides insight about the historical and forecasted patient pool of Oral Mucositis in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan
  • The report helps to recognize the growth opportunities in the 7MM with respect to the patient population
  • The report assesses the disease risk and burden and highlights the unmet needs of Oral Mucositis
  • The report provides the segmentation of the Oral Mucositis epidemiology


Report Highlights

  • 11-Year Forecast of Oral Mucositis epidemiology
  • 7MM Coverage
  • Total Cases of Oral Mucositis
  • Total Cases of Oral Mucositis according to segmentation
  • Diagnosed cases of Oral Mucositis


Request for Sample Pages :


“As per DelveInsight insights, the incidence of Grade I and II OM has been observed to be higher in comparison to Grade III-IV cases across all the major markets”


KOL- Views

We interview, KOLs and SME’s opinion through primary research to fill the data gaps and validate our secondary research. The opinion helps to understand the total patient population and current treatment pattern. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the indications.


Key Questions Answered

  • What will be the growth opportunities in the 7MM with respect to the patient population pertaining to Oral Mucositis?
  • What are the key findings pertaining to the Oral Mucositis epidemiology across 7MM and which country will have the highest number of patients during the forecast period (2017-2030)?
  • What would be the total number of patients of Oral Mucositis across the 7MM during the forecast period (2017-2030)?
  •  Among the EU5 countries, which country will have the highest number of patients during the forecast period (2017-2030)?
  • At what CAGR the patient population is expected to grow in 7MM during the forecast period (2017-2030)?
  • What is the disease risk, burden and unmet needs of the Oral Mucositis?
  • What are the currently available treatments of Oral Mucositis?


Reasons to buy

  • The Oral Mucositis Epidemiology report will allow the user to –
  • Develop business strategies by understanding the trends shaping and driving the global Oral Mucositis market
  • Quantify patient populations in the global Oral Mucositis market to improve product design, pricing, and launch plans
  • Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for Oral Mucositis therapeutics in each of the markets covered
  • Understand the magnitude of Oral Mucositis population by its epidemiology
  • The Oral Mucositis Epidemiology Model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over 11-year forecast period using reputable sources


Key Assessments

  • Patient Segmentation
  • Disease Risk and Burden
  • Risk of disease by the segmentation
  • Factors driving growth in a specific patient population


Related Reports:

 Oral Mucositis – Pipeline Insights, 2020

The Oral Mucositis report provides an overview of therapeutic pipeline activity and therapeutic assessment of the products by development stage, product type, route of administration, molecule type, and MOA type for Oral Mucositis across the complete product development cycle, including all clinical and nonclinical stages.

 Oral Mucositis (OM)- Market Insight, Epidemiology and Market Forecast -2030

The Oral Mucositis (OM) market report provides current treatment practices, emerging drugs, Oral Mucositis (OM) market share of the individual therapies, current and forecasted Oral Mucositis (OM) market Size from 2017 to 2030 segmented by seven major markets.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: +919650213330
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States